Case Study: Dana-Faber Cancer Institute
Case Description
The case involves Dr. Barret Rollins, Chief Scientific Officer (CSO) for the Dana- Faber Cancer Institute, and Diana Cohn, a member of the institute board of trustees. On October 14, 2010 Dr. Rollins received a call from Diana Cohn expressing her concern about the lack of progress regarding the NIH Grant, largely due to miscommunication and lack of collaboration between centers of the institute. Diana Cohn’s remarks stem from dealing with her husband’s battle with Glioblastoma Multiforme, the deadliest type form of brain cancer. There was no cure for her husband’s cancer but research was conducted by the Institute to find a potential cure or treatments for individuals who suffered from the same disease. After hearing Dana Cohn’s
The case involves Dr. Barret Rollins, Chief Scientific Officer (CSO) for the Dana- Faber Cancer Institute, and Diana Cohn, a member of the institute board of trustees. On October 14, 2010 Dr. Rollins received a call from Diana Cohn expressing her concern about the lack of progress regarding the NIH Grant, largely due to miscommunication and lack of collaboration between centers of the institute. Diana Cohn’s remarks stem from dealing with her husband’s battle with Glioblastoma Multiforme, the deadliest type form of brain cancer. There was no cure for her husband’s cancer but research was conducted by the Institute to find a potential cure or treatments for individuals who suffered from the same disease. After hearing Dana Cohn’s